Literature DB >> 19645333

Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.

Katarzyna Sosnowska1, Katarzyna Winnicka, Anna Czajkowska-Kośnik.   

Abstract

In this paper, the stability of enalapril maleate in oral formulations prepared from commercially available tablets was investigated. Extemporaneously compounded, 0.1 mg/mL and 1.0 mg/mL, oral suspensions of enalapril maleate in sugar-containing and sugar-free vehicles were stored in the absence of light at 4 degrees and 25 degrees C for 30 days. Enalapril maleate stability was quantified after 7, 14, 21, and 30 days using HPLC method. Viscosities and pH of prepared suspensions were measured on each study day and no appreciable changes from the initial pH and initial viscosities occurred in any of the samples both at 25 degrees and 4 degrees C. It was shown that all the formulations retain minimum 98% of the initial enalapril maleate concentration after 30 days of storage at 25 degrees and 4 degrees C and they may provide an option in situations where the marketed suspension is unavailable.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19645333

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  2 in total

1.  Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double-masked, randomized clinical trial.

Authors:  Bianca N Lourenço; Amanda E Coleman; Scott A Brown; Chad W Schmiedt; Max C Parkanzky; Kate E Creevy
Journal:  J Vet Intern Med       Date:  2020-11-09       Impact factor: 3.333

2.  A Systematic Review of the Stability of Extemporaneous Pediatric Oral Formulations.

Authors:  Anteneh Belayneh; Zenaw Tessema
Journal:  ScientificWorldJournal       Date:  2021-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.